Company intelligence / Profile preview

Stilo

Swindon, United Kingdom

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Stilo International is a technology company that provides specialized XML content conversion and authoring solutions for the life sciences, aerospace, and manufacturing industries. The company is a leader in helping pharmaceutical organizations comply with regulatory requirements such as the FDA's Structured Product Labeling (SPL) through its automated conversion tools. Its core products, including Migrate and OmniMark, enable the seamless transformation of legacy documentation into structured XML formats for regulatory submissions and enterprise publishing. Stilo's solutions are designed to improve data integrity, reduce manual processing time, and ensure compliance with global healthcare documentation standards.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

IBMBoeingAirbus

Beyond the preview

Go deeper on Stilo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stilo.

Explore the full profile